Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis

Gabriela Spencer-Bonilla1, Joyce N Njoroge2, Keon Pearson1

  • 1Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Insights

Transthyretin amyloid cardiomyopathy (ATTR-CM) affects older adults and Black individuals disproportionately. Addressing disparities in diagnosis and treatment is crucial for improving outcomes in this underrepresented population.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and often fatal condition.
  • ATTR-CM is increasingly recognized as a significant cause of heart failure, particularly in older adults.
  • Historically underestimated, ATTR-CM prevalence is higher in specific demographics, including individuals of African descent.

Purpose of the Study:

  • To review current knowledge on racial and ethnic disparities in ATTR-CM diagnosis and management.
  • To highlight the disproportionate impact of ATTR-CM on older adults and people of African descent.
  • To examine existing gaps in clinical data and trial representation for minority populations.

Main Methods:

  • Literature review of existing studies on ATTR-CM.
  • Analysis of demographic data concerning ATTR-CM prevalence and diagnosis.
  • Examination of clinical trial participation rates across racial and ethnic groups.

Main Results:

  • ATTR-CM is more prevalent in older adults and people of African descent than previously thought.
  • Significant geographic variations exist in ATTR-CM diagnosis.
  • Black patients are underrepresented in clinical trials and data sets for ATTR-CM.
  • Socioeconomic factors, including cost and access to therapies, exacerbate disparities.

Conclusions:

  • Earlier identification of ATTR-CM in primary care settings can improve outcomes for all patient groups.
  • Future clinical trials must prioritize enrollment of a higher proportion of Black patients.
  • Enhanced strategies are needed to improve access to disease-modifying therapies for affected racial and ethnic minority groups.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
68
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
96
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
92.0K